Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
BACKGROUND: Patients with permanent neonatal diabetes usually present within the first three months of life and require insulin treatment. In most, the cause is unknown. Because ATP-sensitive potassium (K(ATP)) channels mediate glucose-stimulated insulin secretion from the pancreatic beta cells, we...
Egile Nagusiak: | Gloyn, A, Pearson, E, Antcliff, J, Proks, P, Bruining, G, Slingerland, A, Howard, N, Srinivasan, S, Silva, J, Molnes, J, Edghill, E, Frayling, T, Temple, I, Mackay, D, Shield, J, Sumnik, Z, van Rhijn, A, Wales, J, Clark, P, Gorman, S, Aisenberg, J, Ellard, S, Njølstad, P, Ashcroft, F, Hattersley, A |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2004
|
Antzeko izenburuak
-
Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
nork: Proks, P, et al.
Argitaratua: (2005) -
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
nork: Proks, P, et al.
Argitaratua: (2004) -
Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
nork: Tammaro, P, et al.
Argitaratua: (2005) -
Focus on Kir6.2: a key component of the ATP-sensitive potassium channel.
nork: Haider, S, et al.
Argitaratua: (2005) -
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.
nork: Flanagan, SE, et al.
Argitaratua: (2006)